Lixte Biotechnology

+$0.06 (+3.24%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LIXT and other ETFs, options, and stocks.

About LIXT

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company, that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The firm focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development.

CEO
John S. Kovach
Employees
4
Headquarters
East Setauket, New York
Founded
2005

LIXT Key Statistics

Market Cap
26.26M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
38.21K
High Today
$1.92
Low Today
$1.82
Open Price
$1.85
Volume
11.64K
52 Week High
$4.12
52 Week Low
$1.75

LIXT Earnings

-$0.25
-$0.17
-$0.08
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 1, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure